240 related articles for article (PubMed ID: 16502042)
1. Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
Yu JC; Hsu HM; Chen ST; Hsu GC; Huang CS; Hou MF; Fu YP; Cheng TC; Wu PE; Shen CY
J Biomed Sci; 2006 May; 13(3):419-32. PubMed ID: 16502042
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
[TBL] [Abstract][Full Text] [Related]
3. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.
Cheng TC; Chen ST; Huang CS; Fu YP; Yu JC; Cheng CW; Wu PE; Shen CY
Int J Cancer; 2005 Jan; 113(3):345-53. PubMed ID: 15455371
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.
Lo YL; Yu JC; Chen ST; Hsu GC; Mau YC; Yang SL; Wu PE; Shen CY
Carcinogenesis; 2007 May; 28(5):1079-86. PubMed ID: 17210994
[TBL] [Abstract][Full Text] [Related]
6. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.
Fujita N; Jaye DL; Kajita M; Geigerman C; Moreno CS; Wade PA
Cell; 2003 Apr; 113(2):207-19. PubMed ID: 12705869
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of MTA family members in human cancers.
Kumar R; Wang RA; Bagheri-Yarmand R
Semin Oncol; 2003 Oct; 30(5 Suppl 16):30-7. PubMed ID: 14613024
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
10. Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.
Mishra SK; Talukder AH; Gururaj AE; Yang Z; Singh RR; Mahoney MG; Francí C; Vadlamudi RK; Kumar R
J Biol Chem; 2004 Jul; 279(31):32709-15. PubMed ID: 15169784
[TBL] [Abstract][Full Text] [Related]
11. Another tie that binds the MTA family to breast cancer.
Kumar R
Cell; 2003 Apr; 113(2):142-3. PubMed ID: 12705862
[TBL] [Abstract][Full Text] [Related]
12. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
Mishra SK; Mazumdar A; Vadlamudi RK; Li F; Wang RA; Yu W; Jordan VC; Santen RJ; Kumar R
J Biol Chem; 2003 May; 278(21):19209-19. PubMed ID: 12639951
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility.
Ding SL; Yu JC; Chen ST; Hsu GC; Shen CY
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):263-9. PubMed ID: 17301258
[TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells.
Fujita N; Kajita M; Taysavang P; Wade PA
Mol Endocrinol; 2004 Dec; 18(12):2937-49. PubMed ID: 15358836
[TBL] [Abstract][Full Text] [Related]
15. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.
Toh Y; Nicolson GL
Clin Exp Metastasis; 2009; 26(3):215-27. PubMed ID: 19116762
[TBL] [Abstract][Full Text] [Related]
16. Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.
Brüning A; Blankenstein T; Jückstock J; Mylonas I
Cancer Metastasis Rev; 2014 Dec; 33(4):943-51. PubMed ID: 25319202
[TBL] [Abstract][Full Text] [Related]
17. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
18. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
[TBL] [Abstract][Full Text] [Related]
19. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
20. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
